PROVIDER PROFILE · NPI 1649384371

Alan AstrowMD

Hematology-OncologyBrooklyn, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

272

Unique beneficiaries

—

Total services

463

Distinct HCPCS

Medicare payment

$29K

Peer benchmark

Total Medicare services vs. 628 Hematology-Oncology providers in NY — below median (cohort median 883).

PRESCRIBING · PART D · 2024

Total Rx claims

118

Beneficiaries

—

Total drug cost

$3K

Distinct drugs

Brand share

0.0%

Top prescribed drugs

Anastrozole61 claims

Letrozole31 claims

Exemestane13 claims

Tamoxifen Citrate13 claims

QUALITY · MIPS · 2024

Final MIPS score

94.5

Quality

84.7

Cost

71.5

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.82%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$45

Payment records

By payment type

Food and Beverage$45

REFERRAL NETWORK

Where Alan Astrow's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
MAIMONIDES MEDICAL CENTER	152	1,098
Inna Shyknevsky Diagnostic Radiology · New York, NY	29	134
Charusheela Andaz General Surgery · Brooklyn, NY	22	175
Abhinav Chandra Hematology-Oncology · Yuma, AZ	19	44
Seniorcare Emergency Medical Services Inc. Ambulance Service Provider · Bronx, NY	14	23
James Butler Radiation Oncology · Brooklyn, NY	13	41

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history